Responsive luminescent lathanide complexes

US9448225B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9448225-B2
Application numberUS-201314107732-A
CountryUS
Kind codeB2
Filing dateDec 16, 2013
Priority dateJan 30, 2009
Publication dateSep 20, 2016
Grant dateSep 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a compound of formula (I): (wherein: R 1 is an optionally substituted 2-(1-azathiaxanthone); each —R 2 is independently of the formula —CH 2 —C(═O)—R 4 , wherein R 4 is an amino acid or a salt thereof, attached to the remainder of R 2 through the nitrogen atom of the amino group; and R 3 is hydrogen or a C 1-6 alkyl group); or (wherein: R 1 is an optionally substituted 2-(1-azaxanthone); each R 2 is independently an optionally substituted glutaric or succinic acid, or a salt or ester thereof; and R 3 is hydrogen or a C 1-6 alkyl group).

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of the following formula: wherein each -A is —CO 2 H, or a salt thereof; and R 3 is either hydrogen or methyl. 2. The compound of claim 1 , wherein R 3 is hydrogen. 3. The compound of claim 1 , wherein R 3 is methyl. 4. A complex comprising: a lanthanide (III) ion; and a compound of the following formula wherein each -A is —CO 2 H, or a salt thereof; and R 3 is either hydrogen or methyl. 5. The complex of claim 4 , wherein R 3 is hydrogen. 6. The complex of claim 4 , wherein R 3 is methyl. 7. The complex of claim 4 wherein the lanthanide (III) ion is europium (III) or terbium (III). 8. The complex of claim 4 wherein the lanthanide (III) ion is europium (III). 9. A method of analyzing lactate present in a sample of interest, the method comprising: (i) contacting the sample of interest with a complex as defined in claim 4 ; (ii) exciting the azaxanthone; and (iii) determining the quantity or concentration of any lactate in the sample of interest by analysis of the modulation in one or more emission bands resultant from the exciting where citrate is present. 10. A method of analyzing lactate present in a sample of interest, the method comprising: (i) contacting the sample of interest with a complex as defined in claim 7 ; (ii) exciting the azaxanthone; and (iii) determining the quantity or concentration of any lactate in the sample of interest by analysis of the modulation in one or more emission bands resultant from the exciting where citrate is present. 11. A method of analyzing lactate present in a sample of interest, the method comprising: (i) contacting the sample of interest with a complex as defined in claim 8 ; (ii) exciting the azaxanthone; and (iii) determining the quantity or concentration of any lactate in the sample of interest by analysis of the modulation in one or more emission bands resultant from the exciting where citrate is present. 12. A method of, or for use in, the diagnosis of excessive lactic acid comprising: (i) obtaining a liquid sample from a subject; (ii) optionally diluting the liquid sample; and (iii) practicing a method as defined in claim 9 , wherein the liquid sample or the diluted liquid sample constitutes the sample of interest. 13. The method of claim 12 wherein the liquid has been previously obtained from the subject.

Assignees

Inventors

Classifications

  • of the prostate · CPC title

  • Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title

  • containing sulfur as the only heteroatom · CPC title

  • C07D257/02Primary

    not condensed with other rings · CPC title

  • Ortho-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9448225B2 cover?
The invention provides a compound of formula (I): (wherein: R 1 is an optionally substituted 2-(1-azathiaxanthone); each —R 2 is independently of the formula —CH 2 —C(═O)—R 4 , wherein R 4 is an amino acid or a salt thereof, attached to the remainder of R 2 through the nitrogen atom of the amino group; and R 3 is hydrogen or a C 1-6 alkyl group); or…
Who is the assignee on this patent?
Univ Durham
What technology area does this patent fall under?
Primary CPC classification C07D257/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).